| The inhibition of the calcitonin gene-related peptide (CGRP) pathway has attracted interest in the pharmacological research on migraine. |
| Atogepant is a potent, selective, orally available antagonist of the CGRP receptor. |
| Once daily atogepant is an efficacious and overall well-tolerated treatment for the prevention of episodic migraine in adults. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.